Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsLuca Fabris, MD, PhD, FAASLD
Associate Professor Adjunct of Medicine (Digestive Diseases), Internal MedicineAbout
Research
Publications
2026
Heart involvement in alcohol use disorder: observational and retrospective study in a specialized hospital unit and long-term follow-up
Vergadoro M, Zola E, Gottardi G, Di Liberto S, Frigo A, Fabris L, Simioni P. Heart involvement in alcohol use disorder: observational and retrospective study in a specialized hospital unit and long-term follow-up. Internal And Emergency Medicine 2026, 1-13. PMID: 42071131, DOI: 10.1007/s11739-026-04367-1.Peer-Reviewed Original ResearchEpidemiology, Risk Factors and Pathophysiology of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: An Update
Bertin L, Henderson P, Pollok R, Queiroz N, Fabris L, Savarino E, Rodríguez‐Lago I, Barberio B. Epidemiology, Risk Factors and Pathophysiology of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: An Update. 2026, 1 DOI: 10.1002/jcc5.70039.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Banales J, Rodrigues P, Affò S, Andersen J, Aspichueta P, Boulter L, Bridgewater J, Calvisi D, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall T, Khan S, Klümpen H, Koerkamp B, Lamarca A, Lindsey S, Lleo A, Luedde T, Macias R, Morement H, Nault J, Olaizola P, Perugorria M, Raggi C, Rimassa L, Saborowski A, Valle J, Vithayathil M, Vogel A, Braconi C. Cholangiocarcinoma 2026: status quo, unmet needs and priorities. Nature Reviews Gastroenterology & Hepatology 2025, 23: 65-96. PMID: 41372578, DOI: 10.1038/s41575-025-01153-w.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCancer-associated thrombosis in cholangiocarcinoma: Exploring a phenotype of tumor aggressiveness
Fabris L, Frión-Herrera Y, Cadamuro M, Campello E, Simioni P. Cancer-associated thrombosis in cholangiocarcinoma: Exploring a phenotype of tumor aggressiveness. Biochimica Et Biophysica Acta (BBA) - Reviews On Cancer 2025, 1880: 189457. PMID: 40987389, DOI: 10.1016/j.bbcan.2025.189457.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCase Report: jaundice in the young: the complexity of rare diseases beyond cholangiopathies
Guglielmo S, Pasin F, Biolo M, Mescoli C, Vio S, Fabris L, Simioni P. Case Report: jaundice in the young: the complexity of rare diseases beyond cholangiopathies. Frontiers In Gastroenterology 2025, 4: 1579928. PMID: 41822259, PMCID: PMC12952453, DOI: 10.3389/fgstr.2025.1579928.Peer-Reviewed Original Research
2024
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis
Calvaruso V, Celsa C, Cristoferi L, Scaravaglio M, Smith R, Kaur S, Di Maria G, Capodicasa L, Pennisi G, Gerussi A, Nofit E, Malinverno F, Lampertico P, Cazzagon N, Marzioni M, Vespasiani-Gentilucci U, Colapietro F, Andreone P, Lleo A, Rigamonti C, Viganò M, Giannini E, Russello M, Vanni E, Cerini F, Orlandini A, Brunetto M, Niro G, Vettori G, Castellaneta A, Cardinale V, Alvaro D, Mega A, Palitti V, Cossiga V, Morisco F, Bellanti F, Baiocchi L, Fabris L, Persico M, Degasperi E, Labanca S, Bonaiuto E, Pezzato F, Federico A, Petta S, Di Marco V, Mells G, Culver E, Invernizzi P, Cammà C, Carbone M. Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis. Clinical Gastroenterology And Hepatology 2024, 23: 1766-1775.e7. PMID: 39674236, DOI: 10.1016/j.cgh.2024.10.020.Peer-Reviewed Original ResearchEditor's Note: Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.
Cadamuro M, Spagnuolo G, Sambado L, Indraccolo S, Nardo G, Rosato A, Brivio S, Caslini C, Stecca T, Massani M, Bassi N, Novelli E, Spirli C, Fabris L, Strazzabosco M. Editor's Note: Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma. Cancer Research 2024, 84: 3909. PMID: 39544086, DOI: 10.1158/0008-5472.can-24-3017.Commentaries, Editorials and LettersLiver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice
La Mura V, Cardinale V, De Cristofaro R, De Santis A, Di Minno G, Fabris L, Marra F, Morisco F, Peyvandi F, Pompili M, Santoro C, Zanon E, Castaman G. Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice. Blood Advances 2024, 8: 5725-5734. PMID: 39226466, PMCID: PMC11599981, DOI: 10.1182/bloodadvances.2024013750.Peer-Reviewed Original ResearchAnticoagulants in cirrhosis: main concerns
Campello E, Fabris L, Simioni P. Anticoagulants in cirrhosis: main concerns. Nature Reviews Gastroenterology & Hepatology 2024, 21: 827-828. PMID: 39394378, DOI: 10.1038/s41575-024-00998-x.Peer-Reviewed Original ResearchMachine learning application to histology for the study of cholangiopathies (BiliQML): A chance to put liver biopsy back to its former glory?
Venturin C, Fabris L. Machine learning application to histology for the study of cholangiopathies (BiliQML): A chance to put liver biopsy back to its former glory? AJP Gastrointestinal And Liver Physiology 2024, 327: g733-g736. PMID: 39378378, DOI: 10.1152/ajpgi.00173.2024.Peer-Reviewed Original Research